News
Ankyra Therapeutics is a biotech developing anchored immunotherapies aimed at enhancing the therapeutic window of ...
Discover the key biotech trends moving the industry forward in Europe at a time when there lies uncertainty in global ...
Find out if gene therapy has also find its way into skin diseases. With two approvals in the last 2 years, is it the start of ...
Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...
The European Union has launched the Choose Europe for Science initiative and pledged €500 million in funding to attract US ...
Ascentage Pharma is discovering and developing small molecule drugs for the treatment of cancer that block or degrade protein targets implicated in cancer. It has active clinical programs targeting ...
Stem cell therapy shows early promise for treating Parkinson's. Discover who is in the race to bring this breakthrough to ...
In the heat of the COVID-19 crisis, a wave of vaccine companies stepped into the spotlight with unprecedented speed and visibility. Riding a surge of public and private funding, they raced to develop ...
The recent release of the latest BioRegion Report brought with it some very welcome news for Catalonia, as the autonomous northeastern region of Spain consolidated its place as one of the country’s ...
What are T cell engagers? This class of drugs has shot to fame in recent years because of their ability to harness the immune system. T cell engagers are antibodies that are engineered to recognize ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results